New 'Secure Data Environment' joint offering from GOSH and Aridhia to accelerate clinical research and healthcare innovation

21 May 2025, 2:35 p.m.

Computer screen showing dashboard of data

We are expanding our partnership with Aridhia to include an offer to external partners. The offering will enable healthcare organisations and research institutes to benefit from the investment and experience of our 8-year collaboration, which has seen the successful development of a pioneering secure Digital Research Environment (DRE) at GOSH.

The value of data beyond direct care

Beyond direct care of patients, healthcare data holds immense value for accelerating development of new treatments by supporting research through academia and industry. For data to be used beyond direct care, stricter controls and conditions are required to ensure ethical use and that patient data remains secure, with any information that could identify patients being removed.

Healthcare systems and large scale, collaborative research programs have the technical challenge of dealing with multi-modal data from Electronic Patient Records (EPRs), imaging, diagnostics and genomics and the governance challenges of ensuring patient privacy and respect for the legal and ethical use of those data for particular studies and trials.

The GOSH Secure Digital Research Environment

The GOSH Digital Research Environment is a safe space where patient data can be stored, anonymised and analysed for research purposes.

The platform, which is hosted by Aridhia, is one of the world’s most advanced and mature Secure Data Environments (SDEs) with secure integration into the GOSH EPR system and over 20 years of structured and unstructured clinical and research data.

To date, we have over 400 Workspace projects running on our Aridhia platform, delivering advanced data analysis to a user base of clinicians, researchers and data scientists within GOSH, as well as supporting our collaborative partnership efforts nationally and internationally.

The collaboration and engagement model allows industry partners to bring their new treatment studies to the data and work in secure, audited Workspaces. This means developments of lifesaving new treatments can take place without any data ever being transferred outside of GOSH.

The new offering to external organisations in the system

In partnership with Aridhia, we are now offering a three-tiered service to support other organisations in the system to set up SDEs.

  • Researcher: Workspace provisioning within the GOSH DRE for individual external research projects.
  • Organisation: Dedicated and secure space for an external organisation on the GOSH DRE platform to manage a portfolio of research projects.
  • SDE: Consultancy service for international organisations to support the creation of their own standalone Aridhia SDE.

The offering will dramatically reduce the time, effort, costs, and complexity typically involved in setting up new SDEs by providing:

  • Accelerated deployment of production ready integration and analysis pipelines,
  • Collaborative Workspaces in which projects can start immediately,
  • FAIR data services to work with the complexity of diverse datasets,
  • Full audit and reporting for governance and regulatory use.

The experience and expertise of the GOSH and Aridhia teams will also ensure governance best practice, reduced delivery risk and accelerated time to value making optimal use of available budgets.

Prof Andrew Taylor, Director of Innovation at GOSH “A huge amount of time, investment and combined expertise has gone in to making the GOSH DRE the world-leading platform that it is today. We’re incredibly proud of what the team have achieved and it’s brilliant that we can now share this more widely.”

Prof Neil Sebire, Chief Research Information Officer, GOSH said: “Our goal since the beginning has been to make the best use of the data we have, to accelerate research into potentially life-saving treatments for patients, not only at GOSH but across the world. The introduction of this offering is a significant milestone in that journey.”

David Sibbald, the CEO and Co-Founder of Aridhia said – “Large scale health and biomedical data programs have well understood objectives in terms of patient benefit, digital transformation and economic out puts. The challenge has never really been about strategy, it has always been about delivery and collaboration and that’s what the GOSH and Aridhia partnership intends to bring to the market.”

How to express interest as an external organisation

If you would like to explore how your organisation could benefit from the GOSH x Aridhia SDE offering, complete the short form and a member of the team will be in touch: https://wkf.ms/4ki5537

More about the GOSH DRE and the GOSH x Aridhia partnership

NIHR GOSH CRF celebrates International Clinical Trials Day

On Tuesday 20 May we celebrated International Clinical Trials Day in NIHR GOSH Clinical Research Facility (CRF).

New VR game to help children rehabilitate after brain tumour treatment

The National Institute for Health and Care Research Great Ormond Street Hospital Biomedical Research Centre (NIHR GOSH BRC) is working with partners to develop a new virtual reality (VR) game.

Healthcare Scientist Award Winners 2025

As part of Healthcare Science Week, we hosted an awards ceremony to celebrate our scientists. See the winners for each category below.

Gene therapy offers potential to extend lives of children with rare immune disorder

Children have had their lives changed by a ground-breaking gene therapy treatment at Great Ormond Street Hospital for a rare immunodeficiency.